Cargando…

A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight

Comprehensive screening for non-alcoholic fatty liver disease (NAFLD) may help prompt clinical management of fatty liver disease. A family history, especially of diabetes, has been little studied as a predictor for NAFLD. We characterized the cross-sectional relationship between a family history of...

Descripción completa

Detalles Bibliográficos
Autores principales: De Pergola, Giovanni, Castellana, Fabio, Zupo, Roberta, De Nucci, Sara, Panza, Francesco, Castellana, Marco, Lampignano, Luisa, Di Chito, Martina, Triggiani, Vincenzo, Sardone, Rodolfo, Giannelli, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677812/
https://www.ncbi.nlm.nih.gov/pubmed/34916558
http://dx.doi.org/10.1038/s41598-021-03583-3
_version_ 1784616220731899904
author De Pergola, Giovanni
Castellana, Fabio
Zupo, Roberta
De Nucci, Sara
Panza, Francesco
Castellana, Marco
Lampignano, Luisa
Di Chito, Martina
Triggiani, Vincenzo
Sardone, Rodolfo
Giannelli, Gianluigi
author_facet De Pergola, Giovanni
Castellana, Fabio
Zupo, Roberta
De Nucci, Sara
Panza, Francesco
Castellana, Marco
Lampignano, Luisa
Di Chito, Martina
Triggiani, Vincenzo
Sardone, Rodolfo
Giannelli, Gianluigi
author_sort De Pergola, Giovanni
collection PubMed
description Comprehensive screening for non-alcoholic fatty liver disease (NAFLD) may help prompt clinical management of fatty liver disease. A family history, especially of diabetes, has been little studied as a predictor for NAFLD. We characterized the cross-sectional relationship between a family history of type 2 diabetes (FHT2D) and NAFLD probability in 1185 diabetes-free Apulian (Southern-Italy) subjects aged > 20 years with overweight or obesity not receiving any drug or supplementation. Clinical data and routine biochemistry were analysed. NAFLD probability was defined using the fatty liver index (FLI). A first-degree FHT2D was assessed by interviewing subjects and assigning a score of 0, 1, or 2 if none, only one, or both parents were affected by type 2 diabetes mellitus (T2DM). Our study population featured most females (70.9%, N = 840), and 48.4% (N = 574) of the sample had first-degree FHT2D. After dividing the sample by a FHT2D, we found a higher BMI, Waist Circumference (WC), and diastolic blood pressure shared by FHT2D subjects; they also showed altered key markers of glucose homeostasis, higher triglyceride levels, and worse liver function. FLI scores were significantly lower in subjects without a first-degree FHT2D. After running logistic regression models, a FHT2D was significantly associated with the NAFLD probability, even adjusting for major confounders and stratifying by age (under and over 40 years of age). A FHT2D led to an almost twofold higher probability of NAFLD, regardless of confounding factors (OR 2.17, 95% CI 1.63 to 2.89). A first-degree FHT2D acts as an independent determinant of NAFLD in excess weight phenotypes, regardless of the age group (younger or older than 40 years). A NAFLD risk assessment within multidimensional screening might be useful in excess weight subjects reporting FHT2D even in the absence of diabetes.
format Online
Article
Text
id pubmed-8677812
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86778122021-12-20 A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight De Pergola, Giovanni Castellana, Fabio Zupo, Roberta De Nucci, Sara Panza, Francesco Castellana, Marco Lampignano, Luisa Di Chito, Martina Triggiani, Vincenzo Sardone, Rodolfo Giannelli, Gianluigi Sci Rep Article Comprehensive screening for non-alcoholic fatty liver disease (NAFLD) may help prompt clinical management of fatty liver disease. A family history, especially of diabetes, has been little studied as a predictor for NAFLD. We characterized the cross-sectional relationship between a family history of type 2 diabetes (FHT2D) and NAFLD probability in 1185 diabetes-free Apulian (Southern-Italy) subjects aged > 20 years with overweight or obesity not receiving any drug or supplementation. Clinical data and routine biochemistry were analysed. NAFLD probability was defined using the fatty liver index (FLI). A first-degree FHT2D was assessed by interviewing subjects and assigning a score of 0, 1, or 2 if none, only one, or both parents were affected by type 2 diabetes mellitus (T2DM). Our study population featured most females (70.9%, N = 840), and 48.4% (N = 574) of the sample had first-degree FHT2D. After dividing the sample by a FHT2D, we found a higher BMI, Waist Circumference (WC), and diastolic blood pressure shared by FHT2D subjects; they also showed altered key markers of glucose homeostasis, higher triglyceride levels, and worse liver function. FLI scores were significantly lower in subjects without a first-degree FHT2D. After running logistic regression models, a FHT2D was significantly associated with the NAFLD probability, even adjusting for major confounders and stratifying by age (under and over 40 years of age). A FHT2D led to an almost twofold higher probability of NAFLD, regardless of confounding factors (OR 2.17, 95% CI 1.63 to 2.89). A first-degree FHT2D acts as an independent determinant of NAFLD in excess weight phenotypes, regardless of the age group (younger or older than 40 years). A NAFLD risk assessment within multidimensional screening might be useful in excess weight subjects reporting FHT2D even in the absence of diabetes. Nature Publishing Group UK 2021-12-16 /pmc/articles/PMC8677812/ /pubmed/34916558 http://dx.doi.org/10.1038/s41598-021-03583-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
De Pergola, Giovanni
Castellana, Fabio
Zupo, Roberta
De Nucci, Sara
Panza, Francesco
Castellana, Marco
Lampignano, Luisa
Di Chito, Martina
Triggiani, Vincenzo
Sardone, Rodolfo
Giannelli, Gianluigi
A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
title A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
title_full A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
title_fullStr A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
title_full_unstemmed A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
title_short A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
title_sort family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677812/
https://www.ncbi.nlm.nih.gov/pubmed/34916558
http://dx.doi.org/10.1038/s41598-021-03583-3
work_keys_str_mv AT depergolagiovanni afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT castellanafabio afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT zuporoberta afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT denuccisara afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT panzafrancesco afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT castellanamarco afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT lampignanoluisa afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT dichitomartina afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT triggianivincenzo afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT sardonerodolfo afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT giannelligianluigi afamilyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT depergolagiovanni familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT castellanafabio familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT zuporoberta familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT denuccisara familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT panzafrancesco familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT castellanamarco familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT lampignanoluisa familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT dichitomartina familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT triggianivincenzo familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT sardonerodolfo familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight
AT giannelligianluigi familyhistoryoftype2diabetesasapredictoroffattyliverdiseaseindiabetesfreeindividualswithexcessivebodyweight